Ocular Therapeutix (OCUL)
Develops hydrogel-delivered retinal therapies and commercial ophthalmic drug inserts.
$9.85
vs last close−0.66 (−6.24%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
−$0.36
Revenue estimate
$14.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.29−$0.37−$0.39−$0.37−$0.29−$0.41−$0.35Pending
Estimate−$0.24−$0.29−$0.35−$0.39−$0.33−$0.32−$0.40−$0.36
Surprise−20.8%−27.6%−11.4%+5.1%+12.1%−28.1%+11.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$17.1M$10.6M$13.5M$14.5M$13.3M$10.8M$13.5MPending
Estimate$17.1M$13.1M$14.6M$16.1M$16.1M$12.7M$13.2M$14.3M
Surprise−0.2%−18.8%−7.6%−9.9%−17.8%−15.2%+2.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.12 | — | — |
| Sep 2028 | −$0.11 | — | — |
| Jun 2028 | −$0.11 | — | — |
| Mar 2028 | −$0.11 | — | — |
| Dec 2027 | −$0.32 | — | — |
| Sep 2027 | −$0.35 | — | — |
| Jun 2027 | −$0.39 | — | — |
| Mar 2027 | −$0.38 | — | — |
| Dec 2026 | −$0.38 | — | — |
| Nov 2026 | −$0.36 | — | — |
| Aug 2026 | −$0.40 | −$0.35 | +11.5% |
| May 2026 | −$0.32 | −$0.41 | −28.1% |
| Feb 2026 | −$0.33 | −$0.29 | +12.1% |
| Nov 2025 | −$0.39 | −$0.37 | +5.1% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.12 | — | — | $101.8M | — | — | — |
| Sep 2028 | −$0.11 | — | — | $101.8M | — | — | — |
| Jun 2028 | −$0.11 | — | — | $101.8M | — | — | — |
| Mar 2028 | −$0.11 | — | — | $101.8M | — | — | — |
| Dec 2027 | −$0.32 | — | — | $43.6M | — | — | — |
| Sep 2027 | −$0.35 | — | — | $29.3M | — | — | — |
| Jun 2027 | −$0.39 | — | — | $15.6M | — | — | — |
| Mar 2027 | −$0.38 | — | — | $12.9M | — | — | — |
| Dec 2026 | −$0.38 | — | — | $14.2M | — | — | — |
| Nov 3, 2026 | −$0.36 | — | — | $14.3M | — | — | — |
| Aug 3, 2026 | −$0.40 | −$0.35 | +11.5% | $13.2M | $13.5M | +2.1% | +2.8% |
| May 5, 2026 | −$0.32 | −$0.41 | −28.1% | $12.7M | $10.8M | −15.2% | −0.6% |
| Feb 5, 2026 | −$0.33 | −$0.29 | +12.1% | $16.1M | $13.3M | −17.8% | +4.2% |
| Nov 4, 2025 | −$0.39 | −$0.37 | +5.1% | $16.1M | $14.5M | −9.9% | −4.5% |
| Aug 5, 2025 | |||||||
| May 5, 2025 | |||||||
| Mar 3, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 6, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 5, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 7, 2020 | |||||||
| May 8, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 10, 2019 | |||||||
| Mar 7, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 8, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 5, 2017 | |||||||
| Mar 10, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 10, 2016 | |||||||
| Nov 10, 2015 | |||||||
| Aug 10, 2015 |